Please assess the completion status of the following clinical trial:

Trial Title: COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age from 18 to 80 year old~* Hospitalization within 12 hours of onset of acute chest pain~* Patient must have suffered a documented acute myocardial infarction~* Coronary occlusion on initial angiography (culprit artery with aTIMI (Thrombolysis in Myocardial Infarction) flow 1 or 0)~* Patient eligible for a revascularization procedure by PTCA (Percutaneous transluminal coronary angioplasty)~Exclusion Criteria:~* Patients with a history of myocardial infarction prior to the current episode~* Patient in cardiogenic shock or with hemodynamic instability~* Patients with severe hepatic or renal dysfunction (GFR ≤30 mL/min)~* Pregnant women or women of childbearing age without contraception~* Treatment with a potent CYP3A4 inhibitor or a P-glycoprotein inhibitor in patients with renal or hepatic impairement~* Association with macrolides (except spiramycin)~* Association with pristinamycin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Colchicine (Type: EXPERIMENTAL): colchicine and standard therapy
- Comparator (Type: NO_INTERVENTION): standard therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).